Magic Genomix
Magic Genomix provides advanced genomic data analysis to personalize cancer treatments. Their solution focuses on measuring DNA repair deficiency (DRD) by analyzing genomic instability concentration, aiming to increase treatment effectiveness, protect patients from adverse effects, and reduce R&D costs. They offer services for pharmaceutical and biotech industries for drug development and for healthcare professionals to stratify patients and predict therapy response. Their primary product, Magic X, analyzes genomic data to calculate concentration, stratify populations, and provide reports, available as a service or a license. Magic X is used to identify drug response signatures and stratify patients for clinical trials, improving therapeutic success and patient selection.
Magic Genomix
Magic Genomix provides advanced genomic data analysis to personalize cancer treatments. Their solution focuses on measuring DNA repair deficiency (DRD) by analyzing genomic instability concentration, aiming to increase treatment effectiveness, protect patients from adverse effects, and reduce R&D costs. They offer services for pharmaceutical and biotech industries for drug development and for healthcare professionals to stratify patients and predict therapy response. Their primary product, Magic X, analyzes genomic data to calculate concentration, stratify populations, and provide reports, available as a service or a license. Magic X is used to identify drug response signatures and stratify patients for clinical trials, improving therapeutic success and patient selection.